HIQA and Health Technology Assessment in Ireland

More documents

Recommendations

Info

Data Inputs • Duration of protection: lifelong • Vaccine efficacy: 95% in HPV-naïve ITT population 0% in HPV-exposed individuals • Delivery of the vaccination programme: – School-based programme (12-19 year olds ) – GP administration (19 - 26 year olds)
Vaccination Scenarios Scenarios Vaccine coverage 1. Annual vaccination of 12-year old girls 80% 2. Annual vaccination of 12-year old girls with catchup to 15 years in 1 st vaccination year 3. Annual vaccination of 12-year old girls with catchup to 17 years in 1 st vaccination year 4. Annual vaccination of 12-year old girls with catchup to 19 years in 1 st vaccination year 5. Annual vaccination of 12-year old girls with catchup to 26 years in 1 st vaccination year 80% 80% 80% 80% (school) 30% (GP)
Page 1 and 2: HIQA and Health Technology Assessme
Page 3 and 4: Healthcare Quality and Safety Frame
Page 5 and 6: Health Information Identifying and
Page 7: Perceptions Sunday Business Post Fe
Page 10 and 11: Health Technology Assessment Object
Page 12 and 13: Health Act 2007 The functions of th
Page 14 and 15: Health Technologies • Includes a
Page 16 and 17: Quality Framework Programme Advisor
Page 18 and 19: Quality Framework Stakeholder engag
Page 20 and 21: HTA Directorate Objectives • Esta
Page 26 and 27: HTA: Challenges • Quality of HTAs
Page 28 and 29: Implementation of HTA: Hindering Fa
Page 30 and 31: 1 st HTA Undertaken Objective: To e
Page 32 and 33: Human Papillomavirus (HPV) Vaccine
Page 36 and 37: Cost of Vaccination • Ex factory
Page 38 and 39: Health Technologies Colorectal Canc
Page 40: Thank You

HIQA and Health Technology Assessment in Ireland

Create successful ePaper yourself

Delete template?

Save as template?